Abstract
The syndrome of polycystic ovaries (PCOS) is a known risk factor for type 2 diabetes mellitus (DM). As the clinical symptoms of PCOS (e.g. hirsutism and menstrual irregularities) are easily recognized, this group of patients is ideal for strategies focusing on prevention and early diagnosis of altered glucose metabolism. The purpose of this study was to define a risk indicator for glucose intolerance in PCOS women with fasting normoglycemia.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Experimental and Clinical Endocrinology & Diabetes
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
